These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33137420)

  • 1. Development of a fast screening method for selecting excipients in formulations using MD simulations, NMR and microscale thermophoresis.
    Indrakumar S; Zalar M; Tschammer N; Pohl C; Nørgaard A; Streicher W; Harris P; Golovanov AP; Peters GHJ
    Eur J Pharm Biopharm; 2021 Jan; 158():11-20. PubMed ID: 33137420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.
    Barata TS; Zhang C; Dalby PA; Brocchini S; Zloh M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics.
    Li M; Falk BT; Lu X; Schroder R; Mccoy M; Xu W; Yin DH; Gindy ME; D'Addio SM; Su Y
    Mol Pharm; 2022 Sep; 19(9):3267-3278. PubMed ID: 35917158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development.
    Goldberg DS; Lewus RA; Esfandiary R; Farkas DC; Mody N; Day KJ; Mallik P; Tracka MB; Sealey SK; Samra HS
    J Pharm Sci; 2017 Aug; 106(8):1971-1977. PubMed ID: 28456733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion ordered NMR spectroscopy measurements as screening method of potential reactions of API and excipients in drug formulations.
    Becht A; Schollmayer C; Wiest J; Heller D; Baumann W; Buschmann H; Holzgrabe U
    J Pharm Biomed Anal; 2019 Jan; 162():41-46. PubMed ID: 30219598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling Insulin Oligomeric States by
    Falk BT; Liang Y; McCoy MA
    J Pharm Sci; 2020 Jan; 109(1):922-926. PubMed ID: 31449814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulating Aggregation Behavior of the Uncharged Peptide Carbetocin.
    Høgstedt UB; Østergaard J; Weiss T; Sjögren H; van de Weert M
    J Pharm Sci; 2018 Mar; 107(3):838-847. PubMed ID: 29162423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
    Dasnoy S; Le Bras V; Préat V; Lemoine D
    Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Thermal Imaging Method for Rapid Screening of Drug-Polymer Miscibility for Solid Dispersion Based Formulation Development.
    Alhijjaj M; Belton P; Fábián L; Wellner N; Reading M; Qi S
    Mol Pharm; 2018 Dec; 15(12):5625-5636. PubMed ID: 30372612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDX and In Silico Docking Reveal that Excipients Stabilize G-CSF via a Combination of Preferential Exclusion and Specific Hotspot Interactions.
    Wood VE; Groves K; Cryar A; Quaglia M; Matejtschuk P; Dalby PA
    Mol Pharm; 2020 Dec; 17(12):4637-4651. PubMed ID: 33112626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Analysis of Peptide-Matrix Interactions in Lyophilized Solids Using Photolytic Labeling.
    Chen Y; Topp EM
    Mol Pharm; 2018 Jul; 15(7):2797-2806. PubMed ID: 29792715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Excipient-Induced Reversible Association of Therapeutic Peptides in Parenteral Formulations.
    D'Addio SM; Su Y; Yin D; Zhang J; Kemp E; Gindy ME
    J Pharm Sci; 2021 Feb; 110(2):850-859. PubMed ID: 32980392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation Behavior of Structurally Similar Therapeutic Peptides Investigated by
    Hjalte J; Hossain S; Hugerth A; Sjögren H; Wahlgren M; Larsson P; Lundberg D
    Mol Pharm; 2022 Mar; 19(3):904-917. PubMed ID: 35104408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.
    Lubach JW; Hau J
    Pharm Res; 2018 Feb; 35(3):65. PubMed ID: 29464409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
    Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
    Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.
    Kamerzell TJ; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    Adv Drug Deliv Rev; 2011 Oct; 63(13):1118-59. PubMed ID: 21855584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.